Dr Tom Becker of Iofina is confident of further growth after 26% increase in H1 revenue

Episode 376,  Oct 01, 2021, 11:59 AM

Dr Tom Becker of Iofina #IOF is confident of further growth after 26% increase in H1 revenue.

Dr Tom Becker of Iofina #IOF is confident of further growth after 26% increase in H1 revenue.

Dr Tom Becker of Iofina is confident of further growth after 26% increase in H1 revenue

Financial Highlights
· Revenue increased by 27% to $19.9m (H1 2020: $15.74m)
· Gross profit increased by 10% to $5.4m (H1 2020: $4.90m)
· EBITDA increased by 18% to $3.5m (H1 2020: $2.9m)
· Operating profit increased by 22% to $2.6m (H1 2020: $2.2m)
· Paycheck Protection Program loans of $1.1m were forgiven
· Profit before and after tax increased by 164% to $3.5m (H1 2020: $1.3m)
· Basic and diluted profit per share was $0.018 (H1 2020: $0.007)

About Iofina

Iofina plc ("Iofina" or the "Company") is the holding company of a group of companies (the "Group") with unique, proven technologies and competencies for producing iodine and halogen-based chemical derivatives.  The Group's business model involves producing a key raw material, iodine, at a low cost and in as an environmentally friendly way as possible, providing the Company's customers vertical integration into high-quality iodine and other halogen based chemical products.